{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:00:55Z","timestamp":1793628055344,"version":"4.5.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Gastric cancer (GC) is a prevalent gastrointestinal malignancy in which ferroptosis, mitochondrial dysfunction, and macrophage reprogramming remarkably contribute to disease progression. However, the molecular interplay among these processes in contributing to GC remains poorly understood. In this study, we identified ferroptosis- and mitochondrial dysfunction-related genes (FMDRGs) implicated in GC through bioinformatics analyses. Among them, aldehyde dehydrogenase 3 family member A2 (ALDH3A2) was identified as a key FMDRG significantly downregulated in GC tissues and cell lines. Functional assays revealed that ALDH3A2 overexpression in GC cell lines suppressed proliferation, migration, and invasion while enhancing ferroptosis, effects that were reversed by GPX4 overexpression. ALDH3A2 also impaired the mitochondrial unfolded protein response (UPR\n                    <jats:sup>mt<\/jats:sup>\n                    ) and induced mitochondrial dysfunction. Restoration of UPR\n                    <jats:sup>mt<\/jats:sup>\n                    ameliorated ALDH3A2-induced mitochondrial dysfunction and ferroptosis. Mechanistically, ALDH3A2 impaired UPR\n                    <jats:sup>mt<\/jats:sup>\n                    by downregulating SLC47A1 through blockade of NRF2 nuclear translocation, leading to mitochondrial dysfunction, GPX4 downregulation, lipid peroxidation, and subsequent ferroptosis. Synergistically, ALDH3A2-induced ferroptosis promoted IL-6 release, which drove macrophage polarization toward the M1 phenotype with elevated IL-1\u03b2 production. This macrophage reprogramming, in turn, inhibited GC cell progression by downregulating PD-L1 expression. Therapeutically, both genistein treatment and ALDH3A2 overexpression significantly attenuated GC progression in vitro and in vivo. These findings elucidate ALDH3A2 as a dual regulator of tumor-intrinsic ferroptosis and tumor-extrinsic immune remodeling in contributing to GC pathogenesis, highlighting its potential as a promising therapeutic target in GC.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-08364-8","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T15:46:27Z","timestamp":1766591187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["ALDH3A2 negatively orchestrates gastric cancer progression through a synergistic induction of ferroptosis and ferroptosis-driven macrophage reprogramming"],"prefix":"10.1038","volume":"17","author":[{"given":"Yuanyuan","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7623-7109","authenticated-orcid":false,"given":"Yuyan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"8364_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348.","journal-title":"Lancet"},{"key":"8364_CR2","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.12998\/wjcc.v8.i9.1608","volume":"8","author":"A Alshehri","year":"2020","unstructured":"Alshehri A, Alanezi H, Kim BS. Prognosis factors of advanced gastric cancer according to sex and age. World J Clin Cases. 2020;8:1608\u201319.","journal-title":"World J Clin Cases"},{"key":"8364_CR3","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.7150\/ijbs.83348","volume":"19","author":"J Li","year":"2023","unstructured":"Li J, Jia YC, Ding YX, Bai J, Cao F, Li F. The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks. Int J Biol Sci. 2023;19:2756\u201371.","journal-title":"Int J Biol Sci"},{"key":"8364_CR4","doi-asserted-by":"publisher","first-page":"115892","DOI":"10.1016\/j.biopha.2023.115892","volume":"169","author":"K Sun","year":"2023","unstructured":"Sun K, Zhi Y, Ren W, Li S, Zhou X, Gao L, et al. The mitochondrial regulation in ferroptosis signaling pathway and its potential strategies for cancer. Biomed Pharmacother. 2023;169:115892.","journal-title":"Biomed Pharmacother"},{"key":"8364_CR5","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1080\/13880209.2022.2099431","volume":"60","author":"R Li","year":"2022","unstructured":"Li R, Yin B, Zeng D, Liu Z. A novobiocin derivative, XN4, triggers ferroptosis in gastric cancer cells via the activation of NOX4. Pharm Biol. 2022;60:1449\u201357.","journal-title":"Pharm Biol"},{"key":"8364_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-02110-0","volume":"29","author":"G Zheng","year":"2024","unstructured":"Zheng G, Liu X, Abuduwufuer A, Yu H, He S, Ji W. Poria cocos inhibits the invasion, migration, and epithelial-mesenchymal transition of gastric cancer cells by inducing ferroptosis in cells. Eur J Med Res. 2024;29:531.","journal-title":"Eur J Med Res"},{"key":"8364_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38800","volume":"10","author":"J Nie","year":"2024","unstructured":"Nie J, Zhang H, Li X, Qin J, Zhou J, Lu Y, et al. Pachymic acid promotes ferroptosis and inhibits gastric cancer progression by suppressing the PDGFRB-mediated PI3K\/Akt pathway. Heliyon. 2024;10:e38800.","journal-title":"Heliyon"},{"key":"8364_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.mito.2022.05.002","volume":"65","author":"ZH Wang","year":"2022","unstructured":"Wang ZH, Chen L, Li W, Chen L, Wang YP. Mitochondria transfer and transplantation in human health and diseases. Mitochondrion. 2022;65:80\u20137.","journal-title":"Mitochondrion"},{"key":"8364_CR9","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.3390\/ijms21165598","volume":"21","author":"Y Luo","year":"2020","unstructured":"Luo Y, Ma J, Lu W. The significance of mitochondrial dysfunction in cancer. Int J Mol Sci. 2020;21:5598.","journal-title":"Int J Mol Sci"},{"key":"8364_CR10","doi-asserted-by":"publisher","first-page":"D571","DOI":"10.1093\/nar\/gkac935","volume":"51","author":"N Zhou","year":"2023","unstructured":"Zhou N, Yuan X, Du Q, Zhang Z, Shi X, Bao J, et al. FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations. Nucleic Acids Res. 2023;51:D571\u201382.","journal-title":"Nucleic Acids Res"},{"key":"8364_CR11","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173:400\u201316.e11.","journal-title":"Cell"},{"key":"8364_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6635526","volume":"2021","author":"X Jiang","year":"2021","unstructured":"Jiang X, Yan Q, Xie L, Xu S, Jiang K, Huang J, et al. Construction and validation of a ferroptosis-related prognostic model for gastric cancer. J Oncol. 2021;2021:6635526.","journal-title":"J Oncol"},{"key":"8364_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"8364_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","volume":"16","author":"R Tibshirani","year":"1997","unstructured":"Tibshirani R. The lasso method for variable selection in the Cox model. Stat Med. 1997;16:385\u201395.","journal-title":"Stat Med"},{"key":"8364_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i11","volume":"36","author":"MB Kursa","year":"2010","unstructured":"Kursa MB, Rudnicki WR. Feature selection with the Boruta package. J Stat Softw. 2010;36:1\u201313.","journal-title":"J Stat Softw"},{"key":"8364_CR16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1214\/08-AOAS169","volume":"2","author":"H Ishwaran","year":"2008","unstructured":"Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS. Random survival forests. Ann Appl Stat. 2008;2:841\u201360.","journal-title":"Ann Appl Stat"},{"key":"8364_CR17","doi-asserted-by":"publisher","first-page":"105934","DOI":"10.1016\/j.biocel.2021.105934","volume":"133","author":"I Smyrnias","year":"2021","unstructured":"Smyrnias I. The mitochondrial unfolded protein response and its diverse roles in cellular stress. Int J Biochem Cell Biol. 2021;133:105934.","journal-title":"Int J Biochem Cell Biol"},{"key":"8364_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/cr.2018.16","volume":"28","author":"A Melber","year":"2018","unstructured":"Melber A, Haynes CM. UPR(mt) regulation and output: a stress response mediated by mitochondrial-nuclear communication. Cell Res. 2018;28:281\u201395.","journal-title":"Cell Res"},{"key":"8364_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1405393","volume":"12","author":"AK Torres","year":"2024","unstructured":"Torres AK, Fleischhart V, Inestrosa NC. Mitochondrial unfolded protein response (UPRmt): what we know thus far. Front Cell Dev Biol. 2024;12:1405393.","journal-title":"Front Cell Dev Biol"},{"key":"8364_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrm.2017.110","volume":"19","author":"T Shpilka","year":"2018","unstructured":"Shpilka T, Haynes CM. The mitochondrial UPR: mechanisms, physiological functions and implications in ageing. Nat Rev Mol Cell Biol. 2018;19:109\u201320.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8364_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102015","volume":"86","author":"V Gambardella","year":"2020","unstructured":"Gambardella V, Castillo J, Tarazona N, Gimeno-Valiente F, Mart\u00ednez-Ciarpaglini C, Cabeza-Segura M, et al. The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target. Cancer Treat Rev. 2020;86:102015.","journal-title":"Cancer Treat Rev"},{"key":"8364_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.canlet.2019.04.032","volume":"456","author":"X Chen","year":"2019","unstructured":"Chen X, Fu E, Lou H, Mao X, Yan B, Tong F, et al. IL-6 induced M1 type macrophage polarization increases radiosensitivity in HPV positive head and neck cancer. Cancer Lett. 2019;456:69\u201379.","journal-title":"Cancer Lett"},{"key":"8364_CR23","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3389\/fimmu.2019.01084","volume":"10","author":"M Orecchioni","year":"2019","unstructured":"Orecchioni M, Ghosheh Y, Pramod AB, Ley K. Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages. Front Immunol. 2019;10:1084.","journal-title":"Front Immunol"},{"key":"8364_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.856296","volume":"13","author":"P Wisitpongpun","year":"2022","unstructured":"Wisitpongpun P, Potup P, Usuwanthim K. Oleamide-mediated polarization of M1 macrophages and IL-1beta production by regulating NLRP3-inflammasome activation in primary human monocyte-derived macrophages. Front Immunol. 2022;13:856296.","journal-title":"Front Immunol"},{"key":"8364_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cyto.2016.06.018","volume":"85","author":"RL Lopes","year":"2016","unstructured":"Lopes RL, Borges TJ, Zanin RF, Bonorino C. IL-10 is required for polarization of macrophages to M2-like phenotype by mycobacterial DnaK (heat shock protein 70). Cytokine. 2016;85:123\u20139.","journal-title":"Cytokine"},{"key":"8364_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00395-017-0622-5","volume":"112","author":"MR Jung","year":"2017","unstructured":"Jung MR, Ma YG, Iyer RP, DeLeon-Pennell KY, Yabluchanskiy A, Garrett MR, et al. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res Cardiol. 2017;112:33.","journal-title":"Basic Res Cardiol"},{"key":"8364_CR27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fimmu.2014.00533","volume":"5","author":"Z Yang","year":"2014","unstructured":"Yang Z, Ming XF. Functions of arginase isoforms in macrophage inflammatory responses: impact on cardiovascular diseases and metabolic disorders. Front Immunol. 2014;5:533.","journal-title":"Front Immunol"},{"key":"8364_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112235","volume":"134","author":"J Wu","year":"2024","unstructured":"Wu J, Jiang L, Wang S, Peng L, Zhang R, Liu ZTGF. beta1 promotes the polarization of M2-type macrophages and activates PI3K\/mTOR signaling pathway by inhibiting ISG20 to sensitize ovarian cancer to cisplatin. Int Immunopharmacol. 2024;134:112235.","journal-title":"Int Immunopharmacol"},{"key":"8364_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07493-x","volume":"20","author":"Z Yin","year":"2020","unstructured":"Yin Z, Wu D, Shi J, Wei X, Jin N, Lu X, et al. Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis. BMC Cancer. 2020;20:1062.","journal-title":"BMC Cancer"},{"key":"8364_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05109-7","volume":"22","author":"Y Ma","year":"2024","unstructured":"Ma Y, Jin J, Xue Z, Zhao J, Cai W, Zhang W. Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for gastric cancer. J Transl Med. 2024;22:381.","journal-title":"J Transl Med"},{"key":"8364_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101835","volume":"40","author":"Q Lv","year":"2024","unstructured":"Lv Q, Shi J, Miao D, Tan D, Zhao C, Xiong Z, et al. miR-1182-mediated ALDH3A2 inhibition affects lipid metabolism and progression in ccRCC by activating the PI3K-AKT pathway. Transl Oncol. 2024;40:101835.","journal-title":"Transl Oncol"},{"key":"8364_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147515","volume":"876","author":"H Dong","year":"2023","unstructured":"Dong H, He L, Sun Q, Zhan J, Li J, Xiong X, et al. Inhibit ALDH3A2 reduce ovarian cancer cells survival via elevating ferroptosis sensitivity. Gene. 2023;876:147515.","journal-title":"Gene"},{"key":"8364_CR33","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1182\/blood.2019001808","volume":"136","author":"RZ Yusuf","year":"2020","unstructured":"Yusuf RZ, Saez B, Sharda A, van Gastel N, Yu VWC, Baryawno N, et al. Aldehyde dehydrogenase 3a2 protects AML cells from oxidative death and the synthetic lethality of ferroptosis inducers. Blood. 2020;136:1303\u201316.","journal-title":"Blood"},{"key":"8364_CR34","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1182\/blood-2023-174357","volume":"142","author":"Y Huang","year":"2023","unstructured":"Huang Y, Jiang X, Jiang L, Zhang Y, Liu F, Yan P, et al. ALDH3A2 regulates ferroptosis by participating in fatty acid synthesis and finally lead to chemotherapy resistance in acute myeloid leukemia. Blood. 2023;142:2935.","journal-title":"Blood"},{"key":"8364_CR35","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.3390\/ijms22063245","volume":"22","author":"LX Zampieri","year":"2021","unstructured":"Zampieri LX, Silva-Almeida C, Rondeau JD, Sonveaux P. Mitochondrial transfer in cancer: a comprehensive review. Int J Mol Sci. 2021;22:3245.","journal-title":"Int J Mol Sci"},{"key":"8364_CR36","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41419-024-07049-y","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang X, Fan Y, Tan K. A bird\u2019s eye view of mitochondrial unfolded protein response in cancer: mechanisms, progression and further applications. Cell Death Dis. 2024;15:667.","journal-title":"Cell Death Dis"},{"key":"8364_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgac056","volume":"1","author":"V Viswanathan","year":"2022","unstructured":"Viswanathan V, Cao H, Saiki J, Jiang D, Mattingly A, Nambiar D, et al. Aldehyde dehydrogenase 3A1 deficiency leads to mitochondrial dysfunction and impacts salivary gland stem cell phenotype. PNAS Nexus. 2022;1:pgac056.","journal-title":"PNAS Nexus"},{"key":"8364_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41419-023-05557-x","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, Shi X, Chen Z, Xu J, Zhao R, Liu Y, et al. Aldehyde dehydrogenase 2 alleviates mitochondrial dysfunction by promoting PGC-1\u03b1-mediated biogenesis in acute kidney injury. Cell Death Dis. 2023;14:45.","journal-title":"Cell Death Dis"},{"key":"8364_CR39","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.3390\/cells11152401","volume":"11","author":"E Panieri","year":"2022","unstructured":"Panieri E, Pinho SA, Afonso GJM, Oliveira PJ, Cunha-Oliveira T, Saso L. NRF2 and mitochondrial function in cancer and cancer stem cells. Cells. 2022;11:2401.","journal-title":"Cells"},{"key":"8364_CR40","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature10189","volume":"475","author":"GM DeNicola","year":"2011","unstructured":"DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, et al. Oncogene-induced NRF2 transcription promotes ROS detoxification and tumorigenesis. Nature. 2011;475:106\u20139.","journal-title":"Nature"},{"key":"8364_CR41","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1158\/0008-5472.CAN-12-4499","volume":"73","author":"H Satoh","year":"2013","unstructured":"Satoh H, Moriguchi T, Takai J, Ebina M, Yamamoto M. NRF2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis. Cancer Res. 2013;73:4158\u201368.","journal-title":"Cancer Res"},{"key":"8364_CR42","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/mc.22745","volume":"57","author":"S Tao","year":"2018","unstructured":"Tao S, Rojo de la Vega M, Chapman E, Ooi A, Zhang DD. The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer. Mol Carcinog. 2018;57:182\u201392.","journal-title":"Mol Carcinog"},{"key":"8364_CR43","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.3390\/molecules26113157","volume":"26","author":"T Farkhondeh","year":"2021","unstructured":"Farkhondeh T, Pourbagher-Shahri AM, Azimi-Nezhad M, Forouzanfar F, Brockmueller A, Ashrafizadeh M, et al. Roles of NRF2 in gastric cancer: targeting for therapeutic strategies. Molecules. 2021;26:3157.","journal-title":"Molecules"},{"key":"8364_CR44","doi-asserted-by":"publisher","first-page":"7198","DOI":"10.1128\/MCB.23.20.7198-7209.2003","volume":"23","author":"SB Cullinan","year":"2003","unstructured":"Cullinan SB, Zhang D, Hannink M, Arvisais E, Kaufman RJ, Diehl JA. NRF2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol. 2003;23:7198\u2013209.","journal-title":"Mol Cell Biol"},{"key":"8364_CR45","doi-asserted-by":"publisher","first-page":"106704","DOI":"10.1016\/j.biocel.2024.106704","volume":"178","author":"RN Safakli","year":"2025","unstructured":"Safakli RN, Gray SP, Bernardi N, Smyrnias I. Unveiling a novel signalling pathway involving NRF2 and PGAM5 in regulating the mitochondrial unfolded protein response in stressed cardiomyocytes. Int J Biochem Cell Biol. 2025;178:106704.","journal-title":"Int J Biochem Cell Biol"},{"key":"8364_CR46","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1016\/j.biocel.2013.06.022","volume":"45","author":"F Staud","year":"2013","unstructured":"Staud F, Cerveny L, Ahmadimoghaddam D, Ceckova M. Multidrug and toxin extrusion proteins (MATE\/SLC47); role in pharmacokinetics. Int J Biochem Cell Biol. 2013;45:2007\u201311.","journal-title":"Int J Biochem Cell Biol"},{"key":"8364_CR47","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1101\/gad.13.1.76","volume":"13","author":"K Itoh","year":"1999","unstructured":"Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, et al. Keap1 represses nuclear activation of antioxidant responsive elements by NRF2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999;13:76\u201386.","journal-title":"Genes Dev"},{"key":"8364_CR48","doi-asserted-by":"publisher","first-page":"116930","DOI":"10.1016\/j.biopha.2024.116930","volume":"177","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wang M, Ji C, Liu X, Gu B, Dong T. Macrophage polarization in the tumor microenvironment: emerging roles and therapeutic potentials. Biomed Pharmacother. 2024;177:116930.","journal-title":"Biomed Pharmacother"},{"key":"8364_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112315","volume":"396","author":"X Ju","year":"2020","unstructured":"Ju X, Zhang H, Zhou Z, Chen M, Wang Q. Tumor-associated macrophages induce PD-L1 expression in gastric cancer cells through IL-6 and TNF-\u0251 signaling. Exp Cell Res. 2020;396:112315.","journal-title":"Exp Cell Res"},{"key":"8364_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S2225-4110(16)30082-7","volume":"2","author":"JY Lee","year":"2012","unstructured":"Lee JY, Kim HS, Song YS. Genistein as a potential anticancer agent against ovarian cancer. J Tradit Complement Med. 2012;2:96\u2013104.","journal-title":"J Tradit Complement Med"},{"key":"8364_CR51","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.5114\/aoms.2018.78742","volume":"15","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Bao J, Yang J. Genistein-triggered anticancer activity against liver cancer cell line HepG2 involves ROS generation, mitochondrial apoptosis, G2\/M cell cycle arrest and inhibition of cell migration. Arch Med Sci. 2019;15:1001\u20139.","journal-title":"Arch Med Sci"},{"key":"8364_CR52","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.3390\/cimb43030106","volume":"43","author":"SS Bhat","year":"2021","unstructured":"Bhat SS, Prasad SK, Shivamallu C, Prasad KS, Syed A, Reddy P, et al. Genistein: a potent anti-breast cancer agent. Curr Issues Mol Biol. 2021;43:1502\u201317.","journal-title":"Curr Issues Mol Biol"},{"key":"8364_CR53","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.phymed.2017.12.001","volume":"39","author":"YL Bi","year":"2018","unstructured":"Bi YL, Min M, Shen W, Liu Y. Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, G(0)\/G(1)cell cycle arrest and regulation of STAT3 signalling pathway. Phytomedicine. 2018;39:10\u20136.","journal-title":"Phytomedicine"},{"key":"8364_CR54","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2174\/1568026618666180116122650","volume":"18","author":"F Ardito","year":"2018","unstructured":"Ardito F, Di Gioia G, Pellegrino MR, Muzio LL. Genistein as a potential anticancer agent against head and neck squamous cell carcinoma. Curr Top Med Chem. 2018;18:174\u201381.","journal-title":"Curr Top Med Chem"},{"key":"8364_CR55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s43046-022-00140-5","volume":"34","author":"AM Hussein","year":"2022","unstructured":"Hussein AM, Attaai AH, Zahran AM. Genistein anticancer efficacy during induced oral squamous cell carcinoma: an experimental study. J Egypt Natl Cancer Inst. 2022;34:37.","journal-title":"J Egypt Natl Cancer Inst"},{"key":"8364_CR56","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/13880209.2025.2469607","volume":"63","author":"Z Xiang","year":"2025","unstructured":"Xiang Z, Ma B, Pei X, Wang W, Gong W. Mechanism of action of genistein on breast cancer and differential effects of different age stages. Pharm Biol. 2025;63:141\u201355.","journal-title":"Pharm Biol"},{"key":"8364_CR57","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.3748\/wjg.v10.i12.1822","volume":"10","author":"HB Zhou","year":"2004","unstructured":"Zhou HB, Chen JJ, Wang WX, Cai JT, Du Q. Apoptosis of human primary gastric carcinoma cells induced by genistein. World J Gastroenterol. 2004;10:1822\u20135.","journal-title":"World J Gastroenterol"},{"key":"8364_CR58","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1080\/01635581.2013.810290","volume":"65","author":"YL Liu","year":"2013","unstructured":"Liu YL, Zhang GQ, Yang Y, Zhang CY, Fu RX, Yang YM. Genistein induces G2\/M arrest in gastric cancer cells by increasing the tumor suppressor PTEN expression. Nutr Cancer. 2013;65:1034\u201341.","journal-title":"Nutr Cancer"},{"key":"8364_CR59","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/01635581.2013.776089","volume":"65","author":"K Yanagihara","year":"2013","unstructured":"Yanagihara K, Takigahira M, Mihara K, Kubo T, Morimoto C, Morita Y, et al. Inhibitory effects of isoflavones on tumor growth and cachexia in newly established cachectic mouse models carrying human stomach cancers. Nutr Cancer. 2013;65:578\u201389.","journal-title":"Nutr Cancer"},{"key":"8364_CR60","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/(SICI)1097-0215(19990129)80:3<396::AID-IJC10>3.0.CO;2-1","volume":"80","author":"M Tatsuta","year":"1999","unstructured":"Tatsuta M, Iishi H, Baba M, Yano H, Uehara H, Nakaizumi A. Attenuation by genistein of sodium-chloride-enhanced gastric carcinogenesis induced by N-methyl-N\u2019-nitro-N-nitrosoguanidine in wistar rats. Int J Cancer. 1999;80:396\u20139.","journal-title":"Int J Cancer"},{"key":"8364_CR61","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1124\/pr.111.005538","volume":"64","author":"V Koppaka","year":"2012","unstructured":"Koppaka V, Thompson DC, Chen Y, Ellermann M, Nicolaou KC, Juvonen RO, et al. Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharm Rev. 2012;64:520\u201339.","journal-title":"Pharm Rev"},{"key":"8364_CR62","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/s41388-025-03277-4","volume":"44","author":"S Kong","year":"2025","unstructured":"Kong S, Pan H, Zhang YW, Wang F, Chen J, Dong J, et al. Targeting aldehyde dehydrogenase ALDH3A1 increases ferroptosis vulnerability in squamous cancer. Oncogene. 2025;44:1037\u201350.","journal-title":"Oncogene"},{"key":"8364_CR63","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.3390\/cells11244015","volume":"11","author":"Y Wu","year":"2022","unstructured":"Wu Y, Kram H, Gempt J, Liesche-Starnecker F, Wu W, Schlegel J. ALDH1-mediated autophagy sensitizes glioblastoma cells to ferroptosis. Cells. 2022;11:4015.","journal-title":"Cells"},{"key":"8364_CR64","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0304-4165(96)00126-2","volume":"1335","author":"TL Kelson","year":"1997","unstructured":"Kelson TL, Secor McVoy JR, Rizzo WB. Human liver fatty aldehyde dehydrogenase: microsomal localization, purification, and biochemical characterization. Biochim Biophys Acta. 1997;1335:99\u2013110.","journal-title":"Biochim Biophys Acta"},{"key":"8364_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52814-1","volume":"9","author":"JS Lee","year":"2019","unstructured":"Lee JS, Kim SH, Lee S, Kang JH, Lee SH, Cheong JH, et al. Gastric cancer depends on aldehyde dehydrogenase 3A1 for fatty acid oxidation. Sci Rep. 2019;9:16313.","journal-title":"Sci Rep"},{"key":"8364_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.108019","volume":"154","author":"H Tahiliani","year":"2025","unstructured":"Tahiliani H, Dhayalan A, Li MC, Hsieh HP, Coumar MS. Aldehyde dehydrogenases as drug targets for cancer: SAR and structural biology aspects for inhibitor design. Bioorg Chem. 2025;154:108019.","journal-title":"Bioorg Chem"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08364-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08364-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08364-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:02:38Z","timestamp":1769184158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08364-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8364"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08364-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}